Sodium Hydroxide → 2-(5,5-Dioxo-5,10-dihydrophenothiazin-2-yl)-3-(tetrahydropyran-4-yl)propionic acid

HRID 14996

反応式

HRID 14996 の反応式
C([O:3][C:4]([CH:6]([C:14]1[CH:27]=[CH:26][C:25]2[S:24](=[O:29])(=[O:28])[C:23]3[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=3)[N:17](C(OC(C)(C)C)=O)[C:16]=2[CH:15]=1)[CH2:7][CH:8]1[CH2:13][CH2:12][O:11][CH2:10][CH2:9]1)=[O:5])C.[OH-].[Na+]>CO>[O:29]=[S:24]1(=[O:28])[C:23]2[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=2)[NH:17][C:16]2[CH:15]=[C:14]([CH:6]([CH2:7][CH:8]3[CH2:13][CH2:12][O:11][CH2:10][CH2:9]3)[C:4]([OH:5])=[O:3])[CH:27]=[CH:26][C:25]1=2

参加物

4

反応条件

温度
60 °C

実験手順

700 mg of tert-butyl 2-[1-ethoxycarbonyl-2-(tetrahydropyran-4-yl)ethyl]-5,5-dioxo-5H-phenothiazine-10-carboxylate are suspended in 50 ml of methanol, and 10 ml of 2 M NaOH solution are added. The reaction mixture is stirred at 60° C. for one hour. The methanol is removed under reduced pressure and the reaction mixture is adjusted to pH 4 by addition of concentrated hydrochloric acid. The mixture is extracted three times with in each case 100 ml of ethyl acetate. The combined organic phases are dried over MgSO4 and then concentrated under reduced pressure. This gives 600 mg of 2-(5,5-dioxo-5,10-dihydrophenothiazin-2-yl)-3-(tetrahydropyran-4-yl)propionic acid. C20H21NO5S (387.46), LCMS (ESI): 388.1 (M+H+).

後処理

  1. customThe methanol is removed under reduced pressure
  2. additionthe reaction mixture is adjusted to pH 4 by addition of concentrated hydrochloric acid
  3. extractionThe mixture is extracted three times with in each case 100 ml of ethyl acetate
  4. dry with materialThe combined organic phases are dried over MgSO4
  5. concentrationconcentrated under reduced pressure

出典と根拠

ORDレコード
ord-6181f8ec7ed14919a6aa6148667d3628
出典データセット
uspto-grants-2010_06
特許番号
US07732440B2

関連ノート

読み込み中…